Le Lézard
Classified in: Health, Business
Subject: LAW

UEBT Statement on $575 Million Settlement with Sutter Health over Antitrust Claims


SAN FRANCISCO, Dec. 20, 2019 /PRNewswire/ -- The UFCW & Employers Benefit Trust ("UEBT"), on behalf of the certified class of plaintiffs, and the People of the State of California, today sought preliminary approval of a historic, eve-of-trial settlement resolving all claims in their antitrust class action against Sutter Health and its affiliates.

UEBT Chair Jacques Loveall issued the following statement:

"Our settlement with Sutter represents an extraordinary result for working people, their employers, and every Californian who has struggled with the high cost of healthcare.  From the outset, our goal has been to not only achieve justice for the members of the class, but to also put an end to the anticompetitive behavior that has allowed Sutter to charge inflated prices.  Today, we are asking the Court to approve a settlement that delivers on both of these goals." 

"Our case focused on allegations that Sutter has leveraged its market power to insulate its providers from competition on price and quality, thereby allowing it to charge inflated prices.  After five and a half years of litigation, Sutter has agreed to a one-time cash payment of $575 million to resolve the damages claims of the class and the People's claim for disgorgement.  In addition, Sutter has agreed to comprehensive injunctive relief that will stop the anticompetitive conduct at the heart of this litigation and ensure that Sutter competes on price and quality." 

"It is an honor to represent the union-employer trusts and private and government employers that are members of the class.  We are proud to stand shoulder to shoulder with Attorney General Xavier Becerra and the members of the class in achieving justice and restoring fairness.  This is proof that when we join together, we can achieve great results."

"This is only the beginning of what we can and will accomplish as a united voice for self-funded payors."

Plaintiff Class Counsel: Pillsbury & Coleman, LLP (San Francisco, CA); Farella Braun + Martel LLP (San Francisco, CA); Cohen Milstein Sellers & Toll PLLC (Washington, DC); Kellogg Hansen Todd Figel & Frederick PLLC (Washington, DC); and McCracken, Stemerman & Holsberry, LLP (San Francisco, CA).

Case caption:  UFCW & Employers Benefit Trust, on behalf of itself and all others similarly situated, v. Sutter Health, et al., Case No. CGC-14-538451, pending in San Francisco Superior Court.

Media Contact:  [email protected]

SOURCE UEBT


These press releases may also interest you

at 03:47
Zest Dental Solutions, a global leader in innovative dental solutions proudly announces a strategic partnership with The Pathway. Founded by Justin Moody, DDS and based in Arizona, The Pathway is a continuing education program that teaches dentists...

at 03:34
Medivir AB (STO: MVIR), a pharmaceutical company focused on developing innovative treatments for cancer in areas of high unmet medical need, announced today that its selective cathepsin K inhibitor, MIV-711, has been granted Rare Pediatric Disease...

at 03:16
First quarter Net sales reached SEK 9.4 (13.0) million.The operating result totaled SEK -18.4 (-14.4) million.Earnings per share, basic and diluted, were SEK -0.11 (-0.09).Cash flow from operating activities totaled SEK -7.3 (-12.2) million.CEO...

at 03:03
International medical imaging IT and cybersecurity company Sectra (STO: SECT B) will provide its platform for medical education, Sectra Education Portal, to four university colleges in Denmark. With the solution, they aim to elevate the educational...

at 03:00
Sentrycs, a leading innovator in adaptive counter-drone solutions, is proud to announce its inclusion in the prestigious UK National Protective Security Authority Catalogue of Security Equipment (NPSA CSE).  ...

at 02:22
Swedish Orphan Biovitrum AB (publ) (Sobi®) today announced its report for the first quarter 2024 First Quarter 2024 Total revenue increased 19 per cent, 20 per cent at constant exchange rates, (CER)1, to SEK 6,256 M (5,239)Haematology revenue...



News published on and distributed by: